[2-(4-Isobutylphenyl)-propionic acid in the topical treatment of venous and lymphatic inflammations. Comparative study and statistical evaluation of results].
D000287:Administration, Topical; D000700:Analgesics / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008205:Lymphangitis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010653:Phenylbutazone / Q000008:administration & dosage; D010666:Phenylpropionates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010689:Phlebitis / Q000188:drug therapy*; D013997:Time Factors; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D009824:Ointments; D010666:Phenylpropionates; D010653:Phenylbutazone
L'acido 2-(4 isobutilfenil)-propionico nel trattamento topico delle flogosi venose e linfatiche. Studio comparativo e valutazione statistica dei risultati